Statistically speaking, senior citizens are the most likely demographic to oppose marijuana reform. That’s a big problem when you also consider the fact that senior citizens vote at a higher rate than anyone else. Whenever I look at polling for certain campaign efforts, I always look at the senior citizen polling first. I always sit and daydream about how easy it would be to end marijuana prohibition in state after state if the marijuana reform movement was able to get even a small percentage of those ‘no’ senior citizen voters to change to the ‘yes’ side.

BETHEL — First, it was testicular cancer. Then tumors were found in his lungs.

And when those had finally shrunk — thanks to an aggressive chemotherapy and radiation — Brian Tomasulo learned that the cancer had spread to his brain.

After collapsing at work one day in May 2014, the Newtown resident was rushed to the hospital, where he had surgery to remove an egg-sized tumor from his frontal cortex.

The surgery was successful, but when Tomasulo woke up, he had a whole new set of challenges to deal with.

COLORADO SPRINGS, CO - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based formulation, announces the launch of their cannabinoid-formulated capsule product line. The initial capsule formulations released are CBD, Indica, and Sativa; each of the three types of caps will be available in 25mg, 50mg, and 100mg doses and will be provided in two-dose packs with more size options to be made available in the near future.

An Exploratory Look at Patient Response to Cannabinoid Therapies Applied to a Range of Health Challenges

While there are still no studies conducted in the United States regarding the effectiveness of medical marijuana for treatment of chronic illnesses like chronic pain, researchers in Canada are increasing their research work.

Cannabinoids are a modestly safe and effective treatment for chronic non-cancer pain, according to the results of a systematic review of randomized controlled trials published in the Journal of Neuroimmune Pharmacology.

Researchers conducted a systemic review of 11 placebo-controlled trials conducted from 2010 and 2014 investigating cannabinoids and chronic pain.

Hemp, Inc. (OTC PINK: HEMP) announced today that it has become the newest member of one of the most proactive organizations in the industrial hemp industry, the National Hemp Association. As a Gold member, Hemp, Inc. will be able to reach more hemp businesses with multi-channel exposure. The National Hemp Association (NHA) is a mission-driven, non-profit organization "dedicated to the re-birth of industrial hemp in America which helps connect farmers, processors, manufactures, researchers, investors and policy makers to accelerate the growth of this important industry in the United States."

TAMPA, Fla.--As Neutra Corp. (OTCQB: NTRR) continues working to deliver safer, better solutions for cultivators across North America, cannabis businesses and state agencies are still grappling with the use of potentially harmful pesticides in the nascent industry. A recent independent study found dangerous levels of pesticides in cannabis products in Denver.

“Recalls are bad for the entire industry”

Greenhouse Ventures hosts its first Demo Day Dec. 5

With the cannabis industry booming in states like Colorado, Washington and California, it may be surprising that a new startup has decided to take root in Philadelphia. While marijuana laws are certainly more relaxed in the city thanks to legislation decriminalizing small amounts of weed, Pennsylvania is hardly a bastion of progressive thought when it comes to marijuana legislation. But that could change with the introduction of Greenhouse Ventures’ first Demo Day on Dec. 5.